MiR‐182 inhibits kidney fibrosis by regulating transforming growth factor β1/Smad3 pathway in autosomal dominant polycystic kidney disease
Authors:
- 17 February 2020
- journal article
- research article
- Published by Wiley in IUBMB Life
- Vol. 72 (7) , 1340-1348
Abstract
The aim of the present study was to investigate the molecular mechanism of miR‐182 in kidney fibrosis in polycystic kidney disease (PKD). We measured the expression of miR‐182 in kidney tissue of autosomal dominant PKD. Additionally, we investigated the relationship between miR‐182 and fibrotic protein by transfecting miR‐182 mimics and miR‐182 inhibitor into polycystic kidney cyst‐lined epithelial cells, respectively. Furthermore, we observed the interaction between transforming growth factor β1 (TGF‐β1) and miR‐182 and fibrinogen factors of cyst‐lined epithelial cells after TGF‐β1 intervention, and measured the expression of Smad2 and Smad3 protein. Results are presented as follows: (a) MiR‐182 was positively correlated with fibrosis of cyst‐lined epithelial cells; (b) TGF‐β1 could induce fibrosis of cyst‐lined epithelial cells; (c) the expression of miR‐182 had a remarkably impact on the fibrosis induced by TGF‐β1, but had little effect on the expression of TGF‐β1; (d) the expression of Smad3 protein in TGF‐β1 induce‐cyst‐lined epithelial cells was increased. TGF‐β1 and miR‐182 promoting the fibrosis of polycystic kidney cyst‐lined epithelial cells may be mediated by the TGF‐β1/Smad3 signaling pathway, of which Smad3 was an important regulator.Keywords
Funding Information
- Guangdong Science and Technology Project (A2019416)
- Youth Research Cadre Cultivation Project of Shenzhen People's Hospital (SYKYPY201904)
This publication has 16 references indexed in Scilit:
- Profiling peripheral microRNAs in obesity and type 2 diabetes mellitusAPMIS, 2015
- ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopiesPediatric Nephrology, 2014
- Where are we in diabetic nephropathyCurrent Opinion in Nephrology and Hypertension, 2014
- microRNA in the development of diabetic complicationsClinical Science, 2013
- Transforming Growth Factor-β–Induced Cross Talk Between p53 and a MicroRNA in the Pathogenesis of Diabetic NephropathyDiabetes, 2013
- MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoringNephrology Dialysis Transplantation, 2013
- RETRACTED: Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAsMolecular Therapy, 2013
- Elevated TGFβ–Smad signalling in experimental Pkd1 models and human patients with polycystic kidney diseaseThe Journal of Pathology, 2010
- TGF-β Mediated Epithelial-Mesenchymal Transition in Autosomal Dominant Polycystic Kidney DiseaseYonsei Medical Journal, 2009
- The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathwayKidney International, 2005